Efficacy Study of VA106483 in Males With Nocturia.

Status:
Completed

Trial end date:
2010-08-01

Target enrollment:

Participant gender:

To investigate the effect of VA106483 on nocturia related clinical outcomes compared to placebo.

Phase 2

Vantia Ltd